News : Lung Disease

Researchers create new equation to gauge patient survival to be presented at International Society for Heart and Lung Transplantation Annual Meeting
MONTREAL, April 27, 2013 – The latest research in pulmonary arterial hypertension (PAH) will be revealed today at the International Society for Heart and Lung Transplantation (ISHLT) 33rd Annual Meeting and Scientific Sessions in Montreal,...

Research indicates an overall decrease in pediatric waitlist mortality by 44 percent
MONTREAL, April 25, 2013 – The latest research on children awaiting heart transplant will be presented today at the International Society for Heart and Lung Transplantation (ISHLT) 33rd Annual Meeting and Scientific Sessions in Montreal, Canada. The study set out to determine if waitlist survival has...

A UT Arlington bioengineering researcher has teamed with a UT Southwestern colleague to develop a nanoparticle drug delivery system that will help stimulate lung growth and function after partial lung removal or destructive lung disease.

Kytai Nguyen, an associate professor of bioengineering, is working on the drug-delivery portion of the project, which is funded through a $3.4...

Frisco, Texas, April 9, 2012 – OxySure® Systems, Inc. (OTCBB:OXYS) (“OxySure”), the pioneering manufacturer of life-saving easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced that the Company’s Model 615 portable emergency oxygen unit was used to assist in the save of a manufacturing employee in Manatee County, Florida. This brings the number of saves with the OxySure...

Frisco, Texas, April 6, 2012 – OxySure® Systems, Inc. (OTCBB:OXYS) (“OxySure,” or the “Company”), the pioneering manufacturer of lifesaving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced a conference call to discuss recent developments and financial results.

News release date:   Friday, April 6, 2012
Conference call date and time:  Monday, April 9, 2012, 3:30 pm...